Literature DB >> 12411232

Inpatient antipsychotic drug use in 1998, 1993, and 1989.

Franca Centorrino1, Marion Eakin, Won-Myong Bahk, James P Kelleher, Jessica Goren, Paola Salvatore, Samy Egli, Ross J Baldessarini.   

Abstract

OBJECTIVE: Patterns of clinical use of antipsychotic agents have changed greatly in the past decade. The authors' goal was to examine these patterns.
METHOD: They evaluated medication use in all McLean Hospital inpatients treated with antipsychotic drugs during 3 months in 1998 (N=349) and compared the results with McLean Hospital inpatients treated with antipsychotics in 1993 (N=299) and Boston area inpatients in 1989 (N=50).
RESULTS: The most commonly prescribed antipsychotics in 1998 were atypical agents; olanzapine was prescribed more often than risperidone or quetiapine, which were prescribed more often than other antipsychotics. Two or more antipsychotics were prescribed at some time during their hospitalization for 150 (43%) of the patients in 1998. The total discharge dose in chlorpromazine equivalents for the 349 patients for whom antipsychotics were prescribed at discharge was 371 mg/day, 29% higher than the total discharge dose for patients in 1993 and 46% greater than the dose in 1989. The dose of antipsychotics was greater for patients with psychotic illnesses than for those with affective illnesses. Higher doses were associated with greater clinical improvement, polypharmacotherapy, and younger patient age.
CONCLUSIONS: Emerging trends toward higher total antipsychotic doses and polypharmacotherapy require critical assessments of cost-benefit relationships.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411232     DOI: 10.1176/appi.ajp.159.11.1932

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison.

Authors:  Corrado Barbui; Arcangelo Ciuna; Michela Nosè; Deborah Levi; Margherita Andretta; Scott B Patten; Francesco Amaddeo; Michele Tansella
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

Review 2.  Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Authors:  Juan A Gallego; John Bonetti; Jianping Zhang; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2012-04-24       Impact factor: 4.939

Review 3.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

Review 4.  Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

5.  Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

Authors:  Susan M Essock; Nina R Schooler; T Scott Stroup; Joseph P McEvoy; Ingrid Rojas; Carlos Jackson; Nancy H Covell
Journal:  Am J Psychiatry       Date:  2011-05-02       Impact factor: 18.112

6.  Models of treatment with antipsychotics of the schizophrenic patients.

Authors:  Svjetlana Loga-Zec; Irfan Zulić; Nedzad Mulabegović; Slobodan Loga; Saida Fiseković; Jasna Kusturica
Journal:  Bosn J Basic Med Sci       Date:  2005-11       Impact factor: 3.363

7.  Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia.

Authors:  Ralph E Hoffman; Thomas Fernandez; Brian Pittman; Michelle Hampson
Journal:  Biol Psychiatry       Date:  2010-12-08       Impact factor: 13.382

8.  Aberrant functional organization and maturation in early-onset psychosis: evidence from magnetoencephalography.

Authors:  Tony W Wilson; Donald C Rojas; Peter D Teale; Olivia O Hernandez; Ryan M Asherin; Martin L Reite
Journal:  Psychiatry Res       Date:  2007-08-28       Impact factor: 3.222

Review 9.  Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.

Authors:  Christoph U Correll; Juan A Gallego
Journal:  Psychiatr Clin North Am       Date:  2012-07-24

10.  Reality of auditory verbal hallucinations.

Authors:  Tuukka T Raij; Minna Valkonen-Korhonen; Matti Holi; Sebastian Therman; Johannes Lehtonen; Riitta Hari
Journal:  Brain       Date:  2009-07-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.